{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:26:08Z","timestamp":1707524768657},"reference-count":10,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,1,4]]},"DOI":"10.7759\/cureus.33341","type":"journal-article","created":{"date-parts":[[2023,1,4]],"date-time":"2023-01-04T10:33:54Z","timestamp":1672828434000},"source":"Crossref","is-referenced-by-count":0,"title":["Verapamil-Induced Hypotension in End-Stage Renal Disease: The Role of Calcium Gluconate"],"prefix":"10.7759","author":[{"given":"Neerusha","family":"Kaisbain","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei Juan","family":"Lim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vareeja","family":"Kaisbain","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.2174\/0929867323666160309114246","article-title":"Cardiac arrhythmias in patients with chronic kidney disease: Implications of renal failure for antiarrhythmic drug therapy","volume":"23","author":"Potpara TS","year":"2016","unstructured":"Potpara TS, Jokic V, Dagres N, Marin F, Prostran MS, Blomstrom-Lundqvist C, Lip GY. Cardiac arrhythmias in patients with chronic kidney disease: Implications of renal failure for antiarrhythmic drug therapy. Curr Med Chem. 2016, 23:2070-83. 10.2174\/0929867323666160309114246","journal-title":"Curr Med Chem"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1002\/j.1552-4604.1991.tb01885.x","article-title":"The pharmacokinetics of racemic verapamil in patients with impaired renal function","volume":"31","author":"Zachariah PK","year":"1991","unstructured":"Zachariah PK, Moyer TP, Theobald HM, Frantz RP, Kurtz SB, McCarthy JT, Smith RL. The pharmacokinetics of racemic verapamil in patients with impaired renal function. J Clin Pharmacol. 1991, 31:45-53. 10.1002\/j.1552-4604.1991.tb01885.x","journal-title":"J Clin Pharmacol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/0167-527390084-0","article-title":"The use of calcium with verapamil in the management of supraventricular tachyarrhythmias","volume":"4","author":"Weiss AT","year":"1983","unstructured":"Weiss AT, Lewis BS, Halon DA, et al.. The use of calcium with verapamil in the management of supraventricular tachyarrhythmias. Int J Cardiol. 1983, 4:275-84. 10.1016\/0167-527390084-0","journal-title":"Int J Cardiol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1345\/aph.18318","article-title":"The use of calcium salts in the prevention and management of verapamil-induced hypotension","volume":"34","author":"Moser LR","year":"2000","unstructured":"Moser LR, Smythe MA, Tisdale JE. The use of calcium salts in the prevention and management of verapamil-induced hypotension. Ann Pharmacother. 2000, 34:622-9. 10.1345\/aph.18318","journal-title":"Ann Pharmacother"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-107-5-623","article-title":"Intravenous verapamil for treatment of multifocal atrial tachycardia with and without calcium pretreatment","volume":"107","author":"Salerno DM","year":"1987","unstructured":"Salerno DM, Anderson B, Sharkey PJ, Iber C. Intravenous verapamil for treatment of multifocal atrial tachycardia with and without calcium pretreatment. Ann Intern Med. 1987, 107:623-8. 10.7326\/0003-4819-107-5-623","journal-title":"Ann Intern Med"},{"key":"ref6","unstructured":"DailyMed. Verapamil hydrochloride injection. (2017). https:\/\/dailymed.nlm.nih.gov\/dailymed\/drugInfo.cfm?setid=eff5e83b-f819-4a5b-9746-12bce328d7a7."},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-104-6-791","article-title":"Precipitation of cardiac arrest by verapamil in patients with Wolff-Parkinson-White syndrome","volume":"104","author":"McGovern B","year":"1986","unstructured":"McGovern B, Garan H, Ruskin JN. Precipitation of cardiac arrest by verapamil in patients with Wolff-Parkinson-White syndrome. Ann Intern Med. 1986, 104:791-4. 10.7326\/0003-4819-104-6-791","journal-title":"Ann Intern Med"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1159\/000495617","article-title":"Effect of verapamil on kidney function using radionuclide imaging","volume":"103","author":"Mustafa S","year":"2019","unstructured":"Mustafa S, Elgazzar AH, Kamal N. Effect of verapamil on kidney function using radionuclide imaging. Pharmacology. 2019, 103:173-8. 10.1159\/000495617","journal-title":"Pharmacology"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(85)90164-0","article-title":"Calcium channel blockers in congestive heart failure: theoretic considerations and clinical experience","volume":"78","author":"Colucci WS","year":"1985","unstructured":"Colucci WS, Fifer MA, Lorell BH, Wynne J. Calcium channel blockers in congestive heart failure: theoretic considerations and clinical experience. Am J Med. 1985, 78:9-17. 10.1016\/0002-9343(85)90164-0","journal-title":"Am J Med"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1093\/bja\/72.3.361","article-title":"Overdose of sustained-release verapamil","volume":"72","author":"Barrow PM","year":"1994","unstructured":"Barrow PM, Houston PL, Wong DT. Overdose of sustained-release verapamil. Br J Anaesth. 1994, 72:361-5. 10.1093\/bja\/72.3.361","journal-title":"Br J Anaesth"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/131861-verapamil-induced-hypotension-in-end-stage-renal-disease-the-role-of-calcium-gluconate","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:52:35Z","timestamp":1707508355000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/131861-verapamil-induced-hypotension-in-end-stage-renal-disease-the-role-of-calcium-gluconate"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,4]]},"references-count":10,"URL":"https:\/\/doi.org\/10.7759\/cureus.33341","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,1,4]]}}}